April 2017 Respiratory Health

Yosprala

April 22, 2017

Product Pipeline

The FDA has approved Yosprala (aspirin and omeprazole, Aralez Pharmaceuticals) delayed-release tablets for patients requiring aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of developing aspirin-associated gastric ulcers.

Safe Use of OTC Cough Products: When and How Make a Difference

April 19, 2017

OTC Focus

Cough is a common symptom for which many patients seek advice at urgent care clinics and emergency departments, especially when they experience episodes during peak allergy season due to postnasal drip and congestion.